RGCB researchers receive ₹7 crore grant to develop rapid, biopsy-free cervical cancer detection technology

Researchers at the Rajiv Gandhi Centre for Biotechnology (BRIC-RGCB), Thiruvananthapuram, have received a ₹7 crore grant to develop an automated diagnostic device for detecting early signs of cervical cancer from a blood sample. This will potentially reduce the need for invasive procedures and specialised technical expertise .

The project is supported through the MAHA MedTech Mission, launched by the Anusandhan National Research Foundation (ANRF), Indian Council of Medical Research (ICMR), and the Gates Foundation.

The research is being carried out at RGCB in collaboration with the start-up IndZita Biotech Private Limited, Thiruvananthapuram, and Karkinos Healthcare Private Limited (KHPL), Barshi, Maharashtra, an official release issued by RGCB said.